EDEN PRAIRIE, Minn., June 23, 2020 (GLOBE NEWSWIRE) -- CHF Solutions (NASDAQ:CHFS) today announced the company will host an interactive, physician-led webinar to discuss treatment of fluid overload in pediatric patients greater than 20 kg. Registration is open for the webinar, which will be led by Dr. David Askenazi, M.D. MSPH and will take place on July 9 at 1:00 p.m. EDT.
Fluid overload is associated with significant increases in morbidity and mortality in pediatric patients. Maintaining fluid balance while assuring hemodynamic stability in critically ill pediatric patients is crucial to reduce the risk of morbidity and mortality. Diuretics and traditional CRRT devices are not always optimal for pediatric patients with fluid overload.
The Aquadex SmartFlow™ System is used to remove excess fluid precisely and gently in a way that maintains stable blood flow in the heart and vessels (hemodynamic stability). A retrospective, multi-center study of 32 critically ill pediatric patients showed that 97% of these patients survived to the end of therapy when their fluid overload was treated with the Aquadex system.1
David Askenazi, M.D. MSPH, Director Pediatric and Infant Center for Acute Nephrology (PICAN) University of Alabama Birmingham Children's of Alabama, is a forerunner in pediatric renal support therapy and author of dozens of clinical papers on managing fluid balance and providing kidney support in pediatric patients. He has created and hosts the Neonatal and Infant Course on Kidney Support (NICKS) at Children's of Alabama.
"Ultrafiltration therapy is an effective solution for the underserved pediatric patients suffering from fluid overload," said John Erb, CEO of CHF Solutions. "We appreciate Dr. Askenazi's willingness to share his experience and continue to provide valuable medical education to pediatricians."
Register to participate in this webinar: